TrialBlood2010

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

James N Kochenderfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.